Clinical trial
A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Patients With Preeclampsia With Severe Features
NCT06580405 is registered in ClinicalTrials.gov with Kaneka Medical America LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Patients With Preeclampsia With Severe Features
- Lead sponsor
- Kaneka Medical America LLC
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- November 30, 2029
- Enrollment
- 13 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pre-eclampsia, severe